By proceeding, you agree to our Terms of Use and Privacy Policy.
This year's Immunogenicity Summit brings the FDA together with leading industry and academic experts to discuss the development, application and validation of immunogenicity assays. Learn how to manage drug and target interference and tolerance, understand the impact of pre-existing antibodies and interpret the clinical significance of assay data. Novel modalities including cell and gene therapies are posing new challenges to the industry, all of which will be discussed in-depth at this meeting.
Learn about the critical aspects of immunogenicity assessment and its clinical implications.
Explore how to manage drug and target interference and tolerance, understand the impact of pre-existing antibodies and interpret the clinical significance of assay data.
Partake in interactive discussions, exchange ideas, and foster collaborations that can enhance the design and execution of immunogenicity studies and improve patient care.
Listen to industry professionals who are leaders in the field of immunogenicity assessment and clinical relevance.
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioproce
ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses.
Amador Bioscience is a Translational & Clinical CRO providing global-standard quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research, and regulatory filing services to biopharmaceutical companies in China, USA and EU. Amador is c
Amador Bioscience is a Translational & Clinical CRO providing global-standard quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research, and regulatory filing services to biopharmaceutical companies in China, USA and EU. Amador is committed to facilitating innovative drug developme
Is complexity something bad? We don’t think so. For us, complexity is just a fact of life. There is no point in simplifying something when you’re really just throwing away valuable information. The best thing we can do about complexity is to make it
Is complexity something bad? We don’t think so. For us, complexity is just a fact of life. There is no point in simplifying something when you’re really just throwing away valuable information. The best thing we can do about complexity is to make it manageable. That is what we do with our database s
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.